Bullish
Cumberland Partners Ltd reduced its stake in Johnson & Johnson (NYSE:JNJ) by 12.4% in the fourth quarter, selling 8,440 shares but still holding 59,37...
Johnson & Johnson is establishing a 30,000-square-foot science incubator called the Johnson & Johnson Exchange within the New Jersey Innovation Hub in...
Johnson & Johnson has expanded its MedTech footprint by launching the Shockwave C2 Aero Coronary IVL Catheter and securing naming rights for the New J...
Bullish
Axxcess Wealth Management LLC significantly increased its stake in Johnson & Johnson ($JNJ) during the fourth quarter, purchasing an additional 415,97...
Bullish
Johnson & Johnson has announced a collaboration with the Department of Health – Abu Dhabi (DOH) to establish a global open surgical intelligence netwo...
Bullish
Johnson & Johnson is collaborating with the Department of Health – Abu Dhabi (DOH) to launch a global program for an open surgical intelligence networ...
Neutral
Johnson & Johnson has partnered with the Department of Health – Abu Dhabi to launch a global program aimed at developing an open surgical intelligence...
Bullish
Johnson & Johnson announced on Thursday that its drug nipocalimab has received approval in China. The U.S. drugmaker shared the news via its official ...
Bullish
Banque Cantonale Vaudoise significantly reduced its holdings in Johnson & Johnson (JNJ) by 20.3% in the fourth quarter, selling over 14,500 shares. De...
Bullish
Johnson & Johnson MedTech has launched its fifth-generation Shockwave Medical C2 Aero coronary intravascular lithotripsy (IVL) catheter, designed for ...
Neutral
Johnson & Johnson (JNJ) reported strong Q1 results with revenue up 9.9% and adjusted EPS beating consensus for the fourth quarter. The company's oncol...
Bullish
Portal Innovations, New Brunswick Development Corporation (DEVCO), and HELIX announced that Johnson & Johnson has secured naming rights for the Johnso...
Bullish
Johnson & Johnson has secured naming rights for the central commons area of the New Jersey Innovation Hub (NJIH), a 30,000-square-foot science incubat...
Johnson & Johnson announced positive Phase 2 data for JNJ-1900 in non-small cell lung cancer and network meta-analysis findings for CAPLYTA in major d...
Neutral
BD has appointed Peter Menziuso, a former Johnson & Johnson Vision leader, as the new EVP and president of its Interventional segment, effective June ...
Bullish
TD Private Client Wealth LLC reduced its stake in Johnson & Johnson ($JNJ) by 18.9% in Q4, selling 12,637 shares leaving them with 54,168 shares value...
Bullish
The North Dakota State Investment Board acquired a new stake of 82,529 shares in Johnson & Johnson (NYSE:JNJ) during the fourth quarter, valued at app...
Bullish
Eubel Brady & Suttman Asset Management Inc. significantly reduced its stake in Johnson & Johnson (JNJ) by 40.7% in Q4, but still holds 84,114 shares v...
Neutral
iA Global Asset Management Inc. grew its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 8.5% in the fourth quarter, according to ...
Neutral
iA Global Asset Management Inc. boosted its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 8.5% during the 4th quarter, Holdings ...